The FDA assessed the protection and usefulness of atidarsagene autotemcel based on data from 37 children who been given atidarsagene autotemcel in two solitary-arm, open up-label scientific trials and in an expanded obtain method.[7] Kids who been given cure with atidarsagene autotemcel had been whe